SCHEMBL265247

SCHEMBL265247

C/C=C(\Cl)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL491482 1.00
SCHEMBL491479 1.00
SCHEMBL6916934 0.97
SCHEMBL6915455 0.97
SCHEMBL6913076 0.97
SCHEMBL6915378 0.97
SCHEMBL6918572 0.97
SCHEMBL6916892 0.97
SCHEMBL6914228 0.97
SCHEMBL6913250 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1789029-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF CELL PROLIFERATION Interstitial Therapeutics (CH) 2007-05-30 EP claimed
EP-1747059-A1 PERVAPORATION COMPOSITE MEMBRANES McMaster University (CA) 2007-01-31 EP claimed
WO-2006024489-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF CELL PROLIFERATION INTERSTITIAL THERAPEUTICS (CH) 2006-03-09 WO claimed
WO-2006024490-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF CELL PROLIFERATION INTERSTITIAL THERAPEUTICS (CH) 2006-03-09 WO claimed
WO-2006024491-A1 METHODS AND COMPOSITIONS FOR THE TREATMENT OF CELL PROLIFERATION INTERSTITIAL THERAPEUTICS (CH) 2006-03-09 WO claimed
US-20060000778-A1 high-performance membrane designed for the selective removal of a polar fluid (water) from less polar fluids (organic solvents), by a pervaporation using a composite membrane contaiing ultrafiltration membrane as support ( e.g. cellulose acetate) and a crosslinked copolymer of anionic, cationic monomers MCMASTER UNIVERSITY (CA) 2006-01-05 US claimed
WO-2005102503-A1 PERVAPORATION COMPOSITE MEMBRANES MCMASTER UNIVERSITY (CA) 2005-11-03 WO claimed
US-20260028614-A1 Isotachophoresis for Purification of Nucleic Acids PURIGEN BIOSYSTEMS INC (US) 2026-01-29 US disclosed
US-20250340859-A1 Systems, Devices, and Methods for Isotachophoresis PURIGEN BIOSYSTEMS INC (US) 2025-11-06 US disclosed
US-12428635-B2 Isotachophoresis for purification of nucleic acids PURIGEN BIOSYSTEMS, INC. (US) 2025-09-30 US disclosed
EP-3916090-B1 ISOTACHOPHORESIS FOR PURIFICATION OF NUCLEIC ACIDS PURIGEN BIOSYSTEMS INC (US) 2025-07-23 EP disclosed
US-12359190-B2 Systems, devices, and methods for isotachophoresis PURIGEN BIOSYSTEMS, INC. (US) 2025-07-15 US disclosed
US-12298709-B2 Toner and method for producing toner CANON KABUSHIKI KAISHA (JP) 2025-05-13 US disclosed
US-20020031811-A1 Method of producing alpha-halo-alpha, beta-saturated carbonyl compounds SHOWA DENKO K.K. 2002-03-14 US disclosed
US-20020028491-A1 METHOD OF PRODUCING ALPHA-HALO-ALPHA, BETA-SATURATED CARBONYL COMPOUNDS FROM THE CORRESPONDING ALPHA, BETA UNSURATED COMPOUNDS SHOWA DENKO KABUSHIKI KAISHA (JP) 2002-03-07 US disclosed
US-6184415-B1 ASYMMETRIC HYDROGENATION OF A 2-HALO(ELECTRONEGATIVE)ALKENOIC ACID/SALT (2-HALOACRYLIC ACID OR SALT), USING AN ENANTIOMETRICAL RICHED CATALYST OF 2,2'-BIS(DIARYLPHOSPHINO-PHINO-1,1'-BINAPHTHYL COMPLEX OF RUTHENIUM; HALIDE PROMOTERS ALBEMARLE CORPORATION 2001-02-06 US disclosed
EP-0979877-A2 Method of producing alpha-halo-alpha, beta-saturated carbonyl compounds SHOWA DENKO KABUSHIKI KAISHA (JP) 2000-02-16 EP disclosed
WO-1991003938-A1 ANTIMICROBIAL POLYMERIC COATING ECOLAB INCORPORATED (US) 1991-04-04 WO disclosed
US-4544690-A COATINGS FOR ASPHALT PAVEMENT REICHHOLD CHEMICALS, INCORPORATED (US) 1985-10-01 US disclosed
US-4036772-A Esters made from the reaction product of low molecular weight ethylenically unsaturated acylating agents and oxidized ethylene-propylene interpolymers THE LUBRIZOL CORPORATION (US) 1977-07-19 US disclosed